Doximity Cash Flow from Operating Activities 2020-2025 | DOCS

Doximity cash flow from operating activities for the twelve months ending June 30, 2025 was $0.620B, a 49.12% increase year-over-year.

  • Doximity annual cash flow from operating activities for 2025 was $0.273B, a 48.44% increase from 2024.
  • Doximity annual cash flow from operating activities for 2024 was $0.184B, a 2.5% increase from 2023.
  • Doximity annual cash flow from operating activities for 2023 was $0.18B, a 41.89% increase from 2022.

Doximity Cash Flow from Operating Activities 2020-2025 | DOCS

  • Doximity annual cash flow from operating activities for 2025 was $0.273B, a 48.44% increase from 2024.
  • Doximity annual cash flow from operating activities for 2024 was $0.184B, a 2.5% increase from 2023.
  • Doximity annual cash flow from operating activities for 2023 was $0.18B, a 41.89% increase from 2022.
Related Stocks
Company NameMarket
Cap
Veeva Systems (VEEV)$47.5B
Tempus AI (TEM)$14B
Hims & Hers Health (HIMS)$10.1B
IRhythm Technologies (IRTC)$5.4B
Hinge Health (HNGE)$4.5B
Inspire Medical Systems (INSP)$2.8B
Privia Health (PRVA)$2.7B
Heartflow (HTFL)$2.4B
Enovis (ENOV)$1.8B
10x Genomics (TXG)$1.8B
Phreesia (PHR)$1.8B
Omnicell (OMCL)$1.5B
Schrodinger (SDGR)$1.5B
Azenta (AZTA)$1.4B
Clover Health Investments (CLOV)$1.4B
Claritev (CTEV)$1.2B
Evolent Health (EVH)$1.1B
Fulgent Genetics (FLGT)$666M
Zepp Health (ZEPP)$580M
Veradigm (MDRX)$525M
Standard BioTools (LAB)$485M
Talkspace (TALK)$469M
Butterfly Network (BFLY)$383M
Carlsmed (CARL)$346M
TruBridge (TBRG)$307M
Outset Medical (OM)$252M
SOPHiA GENETICS SA (SOPH)$244M
Health Catalyst (HCAT)$231M
Nyxoah SA (NYXH)$219M
KORU Medical Systems (KRMD)$203M